Renaissance Technologies - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 193 filers reported holding CARDLYTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$1,121
-99.9%
67,935
-70.2%
0.00%
-33.3%
Q3 2022$2,141,000
+4.8%
227,735
+148.8%
0.00%
+50.0%
Q2 2022$2,042,000
-55.1%
91,535
+10.6%
0.00%
-60.0%
Q1 2022$4,549,000
-55.6%
82,735
-46.6%
0.01%
-61.5%
Q4 2021$10,235,000
+624.3%
154,867
+819.9%
0.01%
+550.0%
Q3 2021$1,413,000
-85.6%
16,835
-78.2%
0.00%
-83.3%
Q2 2021$9,816,000
+18.3%
77,335
-67.4%
0.01%
+50.0%
Q1 2020$8,297,000
-65.0%
237,335
-37.1%
0.01%
-55.6%
Q4 2019$23,707,000
+587.2%
377,135
+266.4%
0.02%
+500.0%
Q3 2019$3,450,000102,9350.00%
Other shareholders
CARDLYTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 5,416,116$89,365,91411.46%
KPS Global Asset Management UK Ltd 1,218,830$20,110,69510.97%
WORLDLY PARTNERS MANAGEMENT, LLC 996,881$16,448,53710.50%
General Equity Holdings LP 476,215$7,857,5489.59%
BERYLSON CAPITAL PARTNERS, LLC 195,000$3,217,5008.24%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 454,769$7,503,6895.27%
PB INVESTMENT PARTNERS, L.P. 343,061$5,660,5064.83%
VISA INC. 134,914$2,226,0812.50%
683 Capital Management, LLC 1,760,070$29,041,1562.26%
Antipodean Advisors LLC 20,000$330,0001.69%
View complete list of CARDLYTICS INC shareholders